Another view on the analysis of cardiovascular morbidity/mortality trials†

作者: Gerd K. Rosenkranz

DOI: 10.1002/PST.434

关键词:

摘要: In many morbidity/mortality studies, composite endpoints are considered. Although the primary interest is to demonstrate that an invention delays death, expected death rate often low studies focussing on survival exclusively not feasible. Components of endpoint chosen such their occurrence predictive for time death. Therefore, if non-fatal events censored by censoring no longer independent. As a consequence, analysis components cannot be reasonably performed using classical methods times like Kaplan–Meier estimates or log-rank tests. this paper we visualize impact disregarding dependent during and discuss practicable alternatives studies. context simulations provide evidence copula-based have potential deliver practically unbiased hazards endpoint. At same time, they require minimal assumptions, which important since all assumptions generally verifiable because censoring. there alternative ways analyze more appropriately accounting dependencies among endpoints. Despite limitations mentioned, these can at minimum serve as sensitivity analyses check robustness currently used methods. Copyright © 2010 John Wiley & Sons, Ltd.

参考文章(31)
E. J. Gumbel, Bivariate Exponential Distributions Journal of the American Statistical Association. ,vol. 55, pp. 698- 707 ,(1960) , 10.1080/01621459.1960.10483368
John A Dormandy, Bernard Charbonnel, David JA Eckland, Erland Erdmann, Massimo Massi-Benedetti, Ian K Moules, Allan M Skene, Meng H Tan, Pierre J Lefèbvre, Gordon D Murray, Eberhard Standl, Robert G Wilcox, Lars Wilhelmsen, John Betteridge, Kåre Birkeland, Alain Golay, Robert J Heine, László Korányi, Markku Laakso, Marián Mokáň, Antanas Norkus, Valdis Pirags, Toomas Podar, André Scheen, Werner Scherbaum, Guntram Schernthaner, Ole Schmitz, Jan Škrha, Ulf Smith, Jan Tatoň, Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. The Lancet. ,vol. 366, pp. 1279- 1289 ,(2005) , 10.1016/S0140-6736(05)67528-9
F. Downton, Bivariate Exponential Distributions in Reliability Theory Journal of the Royal Statistical Society: Series B (Methodological). ,vol. 32, pp. 408- 417 ,(1970) , 10.1111/J.2517-6161.1970.TB00852.X
Hicham Skali, Marc A. Pfeffer, Jacobus Lubsen, Scott D. Solomon, Variable Impact of Combining Fatal and Nonfatal End Points in Heart Failure Trials Circulation. ,vol. 114, pp. 2298- 2303 ,(2006) , 10.1161/CIRCULATIONAHA.106.620039
S.D. Al-saadi, D.H. Young, A test for independence in a multivariate exponential distribution with equal correlation coefficients Journal of Statistical Computation and Simulation. ,vol. 14, pp. 219- 227 ,(1982) , 10.1080/00949658208810545
David Oakes, Bivariate survival models induced by frailties Journal of the American Statistical Association. ,vol. 84, pp. 487- 493 ,(1989) , 10.1080/01621459.1989.10478795
Larry Lee, Multivariate Distributions Having Weibull Properties. Journal of Multivariate Analysis. ,vol. 9, pp. 267- 277 ,(1979) , 10.1016/0047-259X(79)90084-8
Sherrie E. Emoto, Peter C. Matthews, A Weibull Model for Dependent Censoring Annals of Statistics. ,vol. 18, pp. 1556- 1577 ,(1990) , 10.1214/AOS/1176347866